| Shannon Diane Smith, | |
|
107b N Union Ave, Cranford, NJ 07016-2371 | |
| (908) 272-3400 | |
| Not Available |
| Full Name | Shannon Diane Smith |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 107b N Union Ave, Cranford, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215603386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | TL-3647 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Diane Smith, 38 Normandie Pl, Cranford, NJ 07016-1960 Ph: (908) 967-8244 | Shannon Diane Smith, 107b N Union Ave, Cranford, NJ 07016-2371 Ph: (908) 272-3400 |
News Archive
Expanding Michigan State University's global health outreach, a team of researchers is working in the Dominican Republic to establish a model for HIV/AIDS care that can be exported to other resource-limited countries.
A typical human cell contains hundreds of mitochondria-energy-producing organelles-that continually fuse and divide. Relatively little is known, however, about why mitochondria undergo this behavior.
This Kaiser Health News and Washington Post story reported by Sandra Boodman, explores the idea of provider-based billing. This approach "allows hospitals that own physician practices and outpatient clinics that meet certain federal requirements to bill separately for the facility as well as for physician services.
Repros Therapeutics Inc. today announced it has commenced preparation for dosing the 3 mg cohort in the Company's low dose study of Proellex® following a safety review of data from women that have completed 8 weeks of treatment at a 1 mg dose. No signals of liver toxicity were detected to date in the 1 mg group. Unexpectedly, low levels of drug activity were detected in this first cohort. The Company plans to commence dosing of the second group, 3 mg Proellex, next week.
Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual property estate.
› Verified 8 days ago
Mrs. Suzanne Pfarr Morley, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 528 Lexington Ave, Cranford, NJ 07016 Phone: 908-370-2285 | |
Isabelle Filiciello, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10 Alden St, Cranford, NJ 07016 Phone: 908-272-3400 | |
Carly Weshner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107b N Union Ave, Cranford, NJ 07016 Phone: 908-272-3400 | |
Erin Murphy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107b N Union Ave, Cranford, NJ 07016 Phone: 908-272-3400 | |
Johanna C Chacon, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10 Alden St, Cranford, NJ 07016 Phone: 908-272-3400 | |
Amna Ismail, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107b N Union Ave, Cranford, NJ 07016 Phone: 908-272-3400 | |
Miss Casey Lynn Bevacqua, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 107b N Union Ave, Cranford, NJ 07016 Phone: 908-272-3400 |